Therapeutic Expertise

Our strategic partnership with healthcare specialists across the Greater Montreal Area ensures ongoing access to patient populations in key therapeutic areas of research, with easy access to matching healthy control subjects through our database of over 120,000 participants; 40,000 of which are active. We recruit new participants through marketing and advertising campaigns using social media, radio and newspaper.

You may also be interested in our cognitive testing expertise.

Since 2013, there has been a noticeable increase in the information provided by the Food and Drug Administration (FDA) on the effects of prescription and over-the-counter medication on driving, such as allergy medications and sleep drugs. More and more, the FDA demands that certain drugs be tested for impaired effects.

Click here to learn more >>

 

Diabetes

With access to over 750 Type I diabetics and 1,500 Type II diabetics, we have a solid enrollment rate of 30 new patients per month.

Dyslipidemia

Our database holds 4,000+ participants with lipid profile (TG, LDL-C & HDL-C) and varying degrees of dyslipidemia.

Hepatitis

We are one of the highest enrolling sites worldwide for Hepatitis B and C patients, both treatment naïve and virologically suppressed.

Impaired Renal Function

We collaborate directly with Dr. Vincent Pichette, M.D., Ph.D. Nephrologist, and have access to over 1,300 patients with mild, moderate and severe renal function impairment, as well as patients requiring dialysis.

Gastrointestinal Disorders

We have conducted over 100 Phase l/ll PK or PD studies involving drugs acting locally in the gastrointestinal tract or systemically.